Summary of findings: corticosteroid and local anaesthetic injection (CS+LA) vs local anaesthetic injection (LA)
Function: · Morton's neuroma
1 finding from 1 review
- no estimate extracted2 studies · 157 participantsLow
Findings
What do systematic reviews say?
4,811 questions · 70,850 findings · 5,139 reviews
No studies found 15,174 · 21.4%GRADE not reported 6,479 · 9.1%Very low 17,330 · 24.5%Low 17,814 · 25.1%Moderate 11,056 · 15.6%High 2,997 · 4.2%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Summary of findings: corticosteroid and local anaesthetic injection (CS+LA) vs local anaesthetic injection (LA)
HRQoL: EQ‐5D (0 to 1; a higher score indicates improved HRQoL) (final values) · Morton's neuroma
1 finding from 1 review
- no estimate extracted1 study · 122 participantsModerate
Summary of findings: corticosteroid and local anaesthetic injection (CS+LA) vs local anaesthetic injection (LA)
Satisfaction: 4‐item Likert scale (dichotomised into satisfied and dissatisfied) · Morton's neuroma
Summary of findings: corticosteroid and local anaesthetic injection… showed no clear difference in satisfaction: Modified Johnson Scale (dichotomised into satisfied… compared with local anaesthetic injection (LA) (low certainty).
1 finding from 1 review
- RR 1.08 [0.63, 1.85]1 study · 35 participantsLow
Summary of findings: corticosteroid and local anaesthetic injection (CS+LA) vs local anaesthetic injection (LA)
Adverse events · Morton's neuroma
It is very uncertain whether summary of findings: corticosteroid and local anaesthetic injection… changes adverse events compared with local anaesthetic injection (LA) (very low certainty).
1 finding from 1 review
- RR 9.84 [1.28, 75.56]2 studies · 157 participantsVery low
Summary of findings: ultrasound‐guided injection of corticosteroid and local anaesthetic (UG CS+LA) vs injection with corticosteroid and anaesthetic
Pain at short term (4 weeks) VAS 10‐cm scale, which was translated to a 0 to 100 scale in which lower scores mean less pain. · Morton's neuroma
1 finding from 1 review
- no estimate extracted2 studies · 116 participantsModerate
Summary of findings: ultrasound‐guided injection of corticosteroid and local anaesthetic (UG CS+LA) vs injection with corticosteroid and anaesthetic
Function: · Morton's neuroma
1 finding from 1 review
- no estimate extracted2 studies · 116 participantsModerate
Summary of findings: ultrasound‐guided injection of corticosteroid and local anaesthetic (UG CS+LA) vs injection with corticosteroid and anaesthetic
Health‐related quality of life · Morton's neuroma
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings: ultrasound‐guided injection of corticosteroid and local anaesthetic (UG CS+LA) vs injection with corticosteroid and anaesthetic
Satisfaction: 4‐item Likert scale (dichotomised into satisfied and dissatisfied) · Morton's neuroma
Summary of findings: ultrasound‐guided injection of corticosteroid… may leads to higher satisfaction: 4‐point Likert scale (dichotomised into satisfied and… compared with non‐ultrasound‐guided injection of corticosteroid and local… (low certainty).
1 finding from 1 review
- RR 1.71 [1.19, 2.44]2 studies · 114 participantsLow
Intervention not reported
Change in absolute walking distance from baseline (m) · people with intermittent claudication
1 finding from 1 review
- Mobile health technologies to improve walking distance in people with intermittent claudication 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 503 participantsLow
Intervention not reported
Change in claudication distance from baseline (m) · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
- Mobile health technologies to improve walking distance in people with intermittent claudication 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
Amputation‐free survival · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
- Mobile health technologies to improve walking distance in people with intermittent claudication 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
Revascularisation‐free survival · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
- Mobile health technologies to improve walking distance in people with intermittent claudication 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
Major adverse cardiovascular events (MACE) · people with intermittent claudication
The intervention showed no clear difference in major adverse cardiovascular events (MACE) (low certainty).
1 finding from 1 review
- Mobile health technologies to improve walking distance in people with intermittent claudication 2024 · Cochrane Headline outcomes onlyRR 1.37 [0.07, 28.17]1 study · 305 participantsLow
Intervention not reported
Major adverse limb events (MALE) · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
- Mobile health technologies to improve walking distance in people with intermittent claudication 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
Above‐ankle amputation · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
- Mobile health technologies to improve walking distance in people with intermittent claudication 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Supervised exercise therapy following vascular intervention vs vascular intervention alone
MWD ‐ change from baseline · people with symptomatic peripheral arterial disease§
1 finding from 1 review
- Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral… 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 89 participantsVery low
Supervised exercise therapy following vascular intervention vs vascular intervention alone
Change from baseline in 6MWT (metres) · people with symptomatic peripheral arterial disease§
1 finding from 1 review
- Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral… 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 49 participantsVery low
Supervised exercise therapy following vascular intervention vs vascular intervention alone
PFWD (change in metres) (4–40 weeks' · people with symptomatic peripheral arterial disease§
1 finding from 1 review
- Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral… 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 87 participantsVery low
Supervised exercise therapy following vascular intervention vs vascular intervention alone
ABI ‐ absolute value · people with symptomatic peripheral arterial disease§
1 finding from 1 review
- Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral… 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 110 participantsVery low
Supervised exercise therapy following vascular intervention vs vascular intervention alone
All‐cause mortality · people with symptomatic peripheral arterial disease§
It is very uncertain whether supervised exercise therapy following vascular intervention changes mortality compared with vascular intervention alone (very low certainty).
1 finding from 1 review
- Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral… 2024 · Cochrane Headline outcomes onlyOR 0.92 [0.42, 2]6 studies · 346 participantsVery low